Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2005
07/05/2005US6913897 Comprises dioxetane compound and phosphatases
07/05/2005US6913896 Assay with reduced background
07/05/2005US6913895 Methods for assaying transglycosylase reactions, and for identifying inhibitors thereof
07/05/2005US6913892 Method of obtaining compositions comprising Y4 specific compounds
07/05/2005US6913889 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections
07/05/2005US6913888 Toll-like receptor 4 mutations
07/05/2005US6913887 Method for detecting hepatitis C virus
07/05/2005US6913886 Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides
07/05/2005US6913885 Diagnosis of psychological disorders; obtain tissue sample, extreact nucleotide sequences, screen fro presence of mutation in preferential sequences, presence of mutation is indicative of psychological disorder
07/05/2005US6913884 Compositions and methods for repetitive use of genomic DNA
07/05/2005US6913883 IGF-1 receptor interacting proteins
07/05/2005US6913881 Methods and compositions for detecting target sequences
07/05/2005US6913880 Method for determining transcription factor activity and its technical uses
07/05/2005US6913879 Concurrent genetic mapping of preferential genomic fragments; neonatal diagnostic screening
07/05/2005US6913878 Comprising contacting a eukaryotic cell sample to a water-soluble tetrazolium salt under conditions in which said tetrazolium salt is converted to a formazan dye in the presence of NADH or NADPH, detecting the presence of the dye
07/05/2005US6913877 Using chromogenic agents to identify and quantify neurotransmitters, toxins, hormones and chemical warfare agents
07/05/2005US6913668 Electrochemical analyzing; multilayer laminated structure
07/05/2005US6913130 Method and apparatus for document processing
07/05/2005CA2283789C Dna polymerases having improved labeled nucleotide incorporation properties
07/05/2005CA2215793C Use of neuronal apoptosis inhibitor protein (naip)
07/05/2005CA2128686C Electrochemical treatment of nucleic acid containing solutions
07/05/2005CA2123811C Type i and type ii surface antigens associated with staphylococcus epidermidis
06/2005
06/30/2005WO2005059779A2 Indexing scheme for formulation workflows
06/30/2005WO2005059692A2 Processing and managing genetic information
06/30/2005WO2005059564A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
06/30/2005WO2005059557A1 Methods of predicting, diagnosing and monitoring term and pre-term labour
06/30/2005WO2005059553A1 The biochip assay and its relative equipment
06/30/2005WO2005059552A1 Method and devices for running reactions on a target plate for maldi mass spectrometry
06/30/2005WO2005059548A1 Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor
06/30/2005WO2005059538A1 Protein analysis method
06/30/2005WO2005059537A1 Immobilized-enzyme microreactor devices for characterization of biomolecular analytes and associated methods
06/30/2005WO2005059517A2 Toll-like receptor assays
06/30/2005WO2005059513A2 Multiplexed electrochemical detection system and method
06/30/2005WO2005059509A2 Biosensors for detecting macromolecules and other analytes
06/30/2005WO2005059507A2 Biosensor and method of making same
06/30/2005WO2005059505A2 Method and kit for the genotypification of hla-b27 based on real time pcr
06/30/2005WO2005059182A2 Reagents and methods for detecting neisseria gonorrhoeae
06/30/2005WO2005059181A1 Carbon electrode surface for attachment of dna and protein molecules
06/30/2005WO2005059180A1 Methods of attaching oligonucleotides and peptides to solid supports using 2,4-hydrazin- (1, 3, 5) triazine-activated solid phases
06/30/2005WO2005059179A1 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
06/30/2005WO2005059178A1 Improved selective ligation and amplification assay
06/30/2005WO2005059177A1 A sensitive and specific test to detect sars coronavirus
06/30/2005WO2005059176A1 Repertoire determination of a lymphocyte b population
06/30/2005WO2005059175A1 Methods and compositions for assaying mutations in nucleic acids and their uses in diagnosis of genetic diseases and cancers
06/30/2005WO2005059174A1 Method and kit for the genotypification of hla-drb based on real time pcr
06/30/2005WO2005059173A1 Lac9 chimeric receptor and uses thereof
06/30/2005WO2005059172A2 Method and nucleic acids for the improved treatment of breast cell proliferative disorders
06/30/2005WO2005059171A1 Use of a mutation in the braf gene for the determination of the malignancy of melanoma cells
06/30/2005WO2005059170A2 Method for the determination of fibrinolytic activity in blood
06/30/2005WO2005059169A1 Medium for identification of micro-organisms
06/30/2005WO2005059168A1 Methods of identifying, selecting and/or characterizing compounds which modulate the activity of a src family kinase
06/30/2005WO2005059167A1 Method for identifying histone deacetylase inhibitors
06/30/2005WO2005059166A1 Method and apparatus for measuring environmental allergen
06/30/2005WO2005059165A2 Methods for detecting bacterial pathogens
06/30/2005WO2005059164A1 Stabilized susceptibility tests of aerobic pathogens
06/30/2005WO2005059163A2 Methods, compositions, and kits for analysis of enzyme activity in cells
06/30/2005WO2005059162A2 Microbial detection and quantification
06/30/2005WO2005059160A2 Identification and verification of methylation marker sequences
06/30/2005WO2005059159A2 Dna polymerase compositions for quantitative pcr and methods thereof
06/30/2005WO2005059156A2 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used
06/30/2005WO2005059138A1 Methods and compounds for altering the load of hepatitis virus
06/30/2005WO2005059125A1 Variants of phosphotriesterases with enhanced and/or altered substrate specificity
06/30/2005WO2005059110A2 Methods and materials for canine breed identification
06/30/2005WO2005059109A2 Molecular signature of the pten tumor suppressor
06/30/2005WO2005059108A2 Gene expression profiles and methods of use
06/30/2005WO2005059105A2 Cdk5 genetic markers associated with galantamine response
06/30/2005WO2005059104A2 Slc5a7 genetic markers associated with age of onset of alzheimer's disease
06/30/2005WO2005059102A2 METHOD FOR OBTAINING AN ENRICHED POPULATION OF siRNA-EXPRESSING CELLS
06/30/2005WO2005059097A2 Methods for high fidelity production of long nucleic acid molecules
06/30/2005WO2005059096A2 Methods for high fidelity production of long nucleic acid molecules with error control
06/30/2005WO2005059092A1 Substrate for cell culture, producing method thereof and screening method for cell culture conditions utilizing the same
06/30/2005WO2005059086A1 Biologically active substance transfer sheet, cell culture kit constituted of cell culture plate and biologically active substance transfer sheet, producing method thereof and method for screening cell culture conditions utilizing the same
06/30/2005WO2005059037A1 Reagent for detecting an analyte
06/30/2005WO2005058962A1 Methods of therapy and diagnosis using targeting of cells that express bclp polypeptides
06/30/2005WO2005058957A2 Ztnf 12, a tumor necrosis factor
06/30/2005WO2005058952A2 Ztnf13, a tumor necrosis factor
06/30/2005WO2005058938A2 Helical synthetic peptides that stimulate cellular cholesterol efflux
06/30/2005WO2005058931A2 Methods and algorithms for identifying genomic regulatory sites
06/30/2005WO2005058479A2 Methods for synthesis of encoded libraries
06/30/2005WO2005058478A1 Molecular stamp for printing biomolecules onto a substrate
06/30/2005WO2005058006A2 Methods and compositions comprising bacteriophage nanoparticles
06/30/2005WO2005045076A3 Improved accuracy array assay system and method
06/30/2005WO2005044989A3 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
06/30/2005WO2005043160A3 Ultrasensitive biochemical sensing platform
06/30/2005WO2005042704A3 Differential enzymatic fragmentation
06/30/2005WO2005040825A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
06/30/2005WO2005040824A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24)
06/30/2005WO2005040822A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 25 (gpr25)
06/30/2005WO2005040791A3 Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
06/30/2005WO2005040405A3 Detecting microbial contamination in grain and related products
06/30/2005WO2005038618A3 Lead molecule cross-reaction prediction and optimization system
06/30/2005WO2005030027A3 Salmonella detection identification
06/30/2005WO2005028617A3 Antisense inhibition of laminin-8 expression to inhibit human gliomas
06/30/2005WO2005027886A3 Methods of preventing or treating recurrence of myocardial infarction
06/30/2005WO2005026376A3 Improved methods for sequencing gc-rich and cct repeat dna templates
06/30/2005WO2005025591A3 CASPASE DERIVED CARDs
06/30/2005WO2005024422A3 Methods for identifying inhibitors
06/30/2005WO2005022164A3 Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8)
06/30/2005WO2005021725A3 Nucleic acid analysis method conducted in small reaction volumes
06/30/2005WO2005020125A3 Methods and systems for profiling biological systems